Sales and Marketing

Showing 15 posts of 11524 posts found.

photo_ivana_magovcevic-liebisch3

Ipsen bolsters executive leadership with two new recruits

April 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma

Ipsen is set to expand its executive leadership team with the announcement of two new recruitments: Dr Ivana Magovčević-Liebisch will …
kris-sterkens-23052017-hr-1

Working Life: Kris Sterkens, Company Group Chairman, Janssen EMEA

April 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing J&J, JJ, Janssen, Johnson & Johnson, Kris Sterkens, pharma

Pharmafile.com sat down with Kris Sterkens, Company Group Chairman of Janssen’s EMEA operations to discuss nearly three decades at the …
essure

Bayer contraceptive implant public backlash brings results

April 12, 2018 Medical Communications, Sales and Marketing Bayer, Essure, biotech, drugs, pharma, pharmaceutical

Bayer’s permanent contraceptive device, Essure, has been at the centre of a public backlash for a number of years, with …
kenneth-newman_credit_verona_pharma

Verona Pharma loses Chief Medical Officer

April 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, pharma, verona pharma

Verona Pharma has revealed that it is to part ways with its Chief Medical Officer at the end of the …
csm_packshot_kineret_814229b3fc

Sobi receives expanded EU approval for Kineret

April 11, 2018 Research and Development, Sales and Marketing Kineret, anti-inflammatory, biotech, drugs, pharma, pharmaceutical, sobi

Joining its current indication as a treatment for rheumatoid arthritis and cryopyrin-associated periodic syndromes, Sobi’s Kineret has been given approval …

Alexion $855m portfolio boost after Wilson Therapeutics buyout

April 11, 2018 Research and Development, Sales and Marketing Alexion, Wilson's Therapeutics, Wilson's disease, biotech, drugs, pharma, pharmaceutical

Alexion Pharmaceuticals is badly in need of alternative revenue streams to Soliris, its mega-blockbuster that could start to face competition …
mylan

Mylan looks to hit Teva where it hurts, eyeing slow-release MS treatment

April 11, 2018 Research and Development, Sales and Marketing Copaxone, Mapi Pharma, Mylan, Teva, biotech, drugs, pharma, pharmaceutical

Mylan has taken several steps recently that seem intended to hit sales of its big rivals on their key products, …
fighting_cancer

Looking to the future of oncology

April 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, oncology, pharma

The oncology field moves so quickly that it can be hard to keep track of the latest innovations. Ben Hargreaves …
800px-prostate_cancer_1

Almost 40% of UK prostate cancer cases are diagnosed late, according to report

April 9, 2018 Medical Communications, Research and Development, Sales and Marketing Cancer, UK, pharma, prostate cancer

A report conducted by charity Orchid has revealed a “worrying trend” in the treatment of prostate cancer, indicating that as …
instagram-3198093_960_720

Facebook takes action against drug peddlers on Instagram

April 9, 2018 Medical Communications, Sales and Marketing Facebook, biotech, drugs, fentanyl, instagram, opioid, opioid epidemic, pharma, pharmaceutical

Facebook can’t catch a break at the moment, after being widely criticised for its practices over the security of users’ …
roche_glass_building

Tecentriq third time lucky after NICE nod in lung cancer

April 9, 2018 Sales and Marketing NICE, Roche, biotech, drugs, lung cancer, pharma, pharmaceutical, tecentriq

After having been knocked by twice by NICE, Roche has finally received a recommendation for Tecentriq’s second-line use in non-small …
merckincweb

Keytruda combo fails at Phase 3 in metastatic melanoma

April 9, 2018 Research and Development, Sales and Marketing Incyte, MSD, keytruda, pharma, trial failure

Shares in biopharma firm Incyte were sent reeling by as much as 20% when the company announced that the results …

Novartis CEO makes mark with $8.7bn AveXis acquisition

April 9, 2018 Sales and Marketing AveXis, Novartis, biotech, drugs, gene therapy, pharma, pharmaceutical

Vas Narasimhan’s first few moves as CEO of Novartis indicate that he is not afraid to take bold risks in …
humira_abbott__4

Samsung Bioepis and Biogen secure licensing deal with Abbvie for Humira biosimilar

April 6, 2018 Medical Communications, Sales and Marketing AbbVie, Biogen, Humira, Imraldi, Samsung Bioepis, biosimilar, pharma

Partners Biogen and Samsung Bioepis have secured the future of their Humira (adalimumab) biosimilar after penning a deal with Abbvie …
The Gateway to Local Adoption Series

Latest content